Document is current
Any future updates will be listed below
-
Authors
Blobner, Jens
Dengler, Laura
Eberle, Constantin
Herold, Julika J.
Xu, Tao
Beck, Alexander
Mühlbauer, Anton
Müller, Katharina J.
Teske, Nico
Karschnia, Philipp
van den Heuvel, Dominic
Schallerer, Ferdinand
Ishikawa-Ankerhold, Hellen
Thon, Niklas
Tonn, Joerg-Christian
Subklewe, Marion
Kobold, Sebastian
Harter, Patrick N.
Buchholz, Veit R.
von Baumgarten, Louisa
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 15 September 2024
First Online: 3 October 2024
Declarations
:
: Jens Blobner: No disclosures. Laura Dengler: No disclosures. Constantin Eberle: No disclosures. Alexander Beck: No disclosures. Julika Herold: No disclosures. Tao Xu: No disclosures. Anton Mühlbauer: No disclosures. Katharina Mueller: No disclosures. Philipp Karschnia: No disclosures. Nico Teske: No disclosures. Dominic van den Heuvel: No disclosures. Ferdinand Schallerer: No disclosures. Hellen Ishikawa-Ankerhold: No disclosures. Marion Subklewe: No disclosures. Niklas Thon: No disclosures. Jörg-Christian Tonn: Research grants from Novocure and Munich Surgical Imaging; and Royalties from Springer Publisher Intl. Marion Subklewe: No disclosures. Sebastian Kobold: S. K. has received honoraria from TCR2 Inc., Miltenyi, Galapagos, Novartis, BMS, and GSK. S. K. is an inventor of several patents in the field of immuno-oncology. S. K. received license fees from TCR2 Inc. and Carina Biotech. S.K. received research support from TCR2 Inc., Tabby Therapeutics, CatalYm GmBH, Plectonic GmBH, and Arcus Bioscience for work unrelated to the manuscript. Patrick N. Harter: No disclosures. Veit R Buchholz: No disclosures. Louisa von Baumgarten: No disclosures.
